Effect of cannabidiol as a neuroprotective agent on neurodevelopmental impairment in rats with neonatal hypoxia
- 27 July 2024
- journal article
- research article
- Published by Elsevier in Brain and Development
- Vol. 46 (9) , 294-301
Abstract
No abstract availableKeywords
Funding Information
- Armstrong Foundation
This publication has 37 references indexed in Scilit:
- Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective dosesPsychopharmacology, 2022
- Pathophysiology of hypoxic–ischemic encephalopathy: a review of the past and a view on the futureActa Neurologica Belgica, 2020
- Novel insights into cerebral palsyJournal of Muscle Research and Cell Motility, 2020
- Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid SystemCNS Drugs, 2018
- Early, Accurate Diagnosis and Early Intervention in Cerebral PalsyJAMA Pediatrics, 2017
- The Revised Neurobehavioral Severity Scale (NSS‐R) for RodentsCurrent Protocols in Neuroscience, 2016
- An Introduction to the Endogenous Cannabinoid SystemBiological Psychiatry, 2016
- Cerebral palsy: causes, pathways, and the role of genetic variantsAmerican Journal of Obstetrics and Gynecology, 2015
- Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain EndotheliumJournal of Neuroimmune Pharmacology, 2015
- Cannabinoid as a neuroprotective strategy in perinatal hypoxic-ischemic injuryNeuroscience Bulletin, 2011